http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 13 Mar 2026 07:00:13 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Stock+Buybacks/InMode+authorizes+share+buyback+program+for+6.38+million+shares/26156294.html <p>InMode Ltd. (NASDAQ: INMD) announced that its board of directors authorized a new share repurchase program for up to 6.38 million ordinary shares, representing approximately 10% of the company's total shares outstanding.</p> <p>The medical technology company repurchased approximately $127.4 million of its outstanding ordinary shares through share repurchase programs in 2025. The company stated it continues to generate cash flow and views repurchasing shares at current valuations as an attractive capital allocation strategy.</p> <p>InMode expects to fund the repurchases with available cash. The company may make repurchases from time to time in the open market or through other permitted means, subject to http://www.streetinsider.com/Stock+Buybacks/InMode+authorizes+share+buyback+program+for+6.38+million+shares/26156294.html Fri, 13 Mar 2026 07:00:13 -0400 INMD O.41658003 http://www.streetinsider.com/Stock+Buybacks/InMode+authorizes+share+buyback+program+for+6.38+million+shares/26156294.html <p>InMode Ltd. (NASDAQ: INMD) announced that its board of directors authorized a new share repurchase program for up to 6.38 million ordinary shares, representing approximately 10% of the company's total shares outstanding.</p> <p>The medical technology company repurchased approximately $127.4 million of its outstanding ordinary shares through share repurchase programs in 2025. The company stated it continues to generate cash flow and views repurchasing shares at current valuations as an attractive capital allocation strategy.</p> <p>InMode expects to fund the repurchases with available cash. The company may make repurchases from time to time in the open market or through other permitted means, subject to http://www.streetinsider.com/Stock+Buybacks/InMode+authorizes+share+buyback+program+for+6.38+million+shares/26156294.html Fri, 13 Mar 2026 07:00:13 -0400 INMD O.41658003 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Mar+13/26156302.html si-local-file:///var/storage/secattach/20260313/26156302.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Mar+13/26156302.html Fri, 13 Mar 2026 07:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Mar+13/26156302.html si-local-file:///var/storage/secattach/20260313/26156302.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Mar+13/26156302.html Fri, 13 Mar 2026 07:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/Press+Releases/InMode+Announces+New+Share+Repurchase+Program/26156285.html <div class="xn-content"> <p><span class="legendSpanClass">YOKNEAM, Israel</span>, <span class="legendSpanClass"><chron>March 13, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode Ltd.</span> (Nasdaq: INMD)</b>, a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the Company's total shares outstanding, representing approximately 6.38 million ordinary shares.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <a http://www.streetinsider.com/Press+Releases/InMode+Announces+New+Share+Repurchase+Program/26156285.html Fri, 13 Mar 2026 07:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/Press+Releases/InMode+Announces+New+Share+Repurchase+Program/26156285.html <div class="xn-content"> <p><span class="legendSpanClass">YOKNEAM, Israel</span>, <span class="legendSpanClass"><chron>March 13, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode Ltd.</span> (Nasdaq: INMD)</b>, a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the Company's total shares outstanding, representing approximately 6.38 million ordinary shares.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <a http://www.streetinsider.com/Press+Releases/InMode+Announces+New+Share+Repurchase+Program/26156285.html Fri, 13 Mar 2026 07:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/PRNewswire/InMode+Announces+New+Share+Repurchase+Program/26156285.html <div class="xn-content"> <p><span class="legendSpanClass">YOKNEAM, Israel</span>, <span class="legendSpanClass"><chron>March 13, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode Ltd.</span> (Nasdaq: INMD)</b>, a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the Company's total shares outstanding, representing approximately 6.38 million ordinary shares.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <a http://www.streetinsider.com/PRNewswire/InMode+Announces+New+Share+Repurchase+Program/26156285.html Fri, 13 Mar 2026 07:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/PRNewswire/InMode+Announces+New+Share+Repurchase+Program/26156285.html <div class="xn-content"> <p><span class="legendSpanClass">YOKNEAM, Israel</span>, <span class="legendSpanClass"><chron>March 13, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode Ltd.</span> (Nasdaq: INMD)</b>, a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the Company's total shares outstanding, representing approximately 6.38 million ordinary shares.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <a http://www.streetinsider.com/PRNewswire/InMode+Announces+New+Share+Repurchase+Program/26156285.html Fri, 13 Mar 2026 07:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++InMode+Ltd.++++++++++++++++++++++++++++Filed+by%3A+Mizrahy+Moshe/26131733.html si-local-file:///var/storage/secattach/20260309/26131733.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++InMode+Ltd.++++++++++++++++++++++++++++Filed+by%3A+Mizrahy+Moshe/26131733.html Mon, 09 Mar 2026 15:39:00 -0400 INMD O.41658003 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++InMode+Ltd.++++++++++++++++++++++++++++Filed+by%3A+Mizrahy+Moshe/26131733.html si-local-file:///var/storage/secattach/20260309/26131733.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++InMode+Ltd.++++++++++++++++++++++++++++Filed+by%3A+Mizrahy+Moshe/26131733.html Mon, 09 Mar 2026 15:39:00 -0400 INMD O.41658003 http://www.streetinsider.com/Press+Releases/InMode+to+Present+at+Upcoming+Investor+Conferences/26064786.html <div class="xn-content"> <p><span class="legendSpanClass">YOKNEAM, <location value="LC/il" idsrc="xmltag.org" >Israel</location></span>, <span class="legendSpanClass"><chron>Feb. 26, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode Ltd.</span> </b>(Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in March:</p> <div id="prni_dvprnejpg176cleft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg176cleft" title="INMODE Logo" src="https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg" alt="INMODE Logo" align="middle" data-name="url$https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1064477%2FInMode_Logo.jpg;width$400;height$223" /></div><p><b>Barclays 28^th Annual Global Healthcare Conference</b></p><p><b>Presenters: </b><person>Yair Malca</person>, Chief Financial Officer </p><p><b>Format:</b> In-person fireside chat moderated by <person>Matt Miksic</person>, Senior Equity Analyst, and one-on-one meetings</p><p><b>Location: </b><location value="LU/us.fl.miami" idsrc="xmltag.org" >Miami, FL</location></p><p><b>When:</b> Wednesday, March 11 at <chron>12:30 pm ET</chron></p><p>A live webcast of the presentation can be accessed <a target="_blank" href="https://event.webcasts.com/starthere.jsp?ei=1753373&amp;tp_key=a8a44922ad&amp;tp_special=8" target="_blank" rel="nofollow">here.</a></p><p><b>Oppenheimer http://www.streetinsider.com/Press+Releases/InMode+to+Present+at+Upcoming+Investor+Conferences/26064786.html Thu, 26 Feb 2026 08:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/Press+Releases/InMode+to+Present+at+Upcoming+Investor+Conferences/26064786.html <div class="xn-content"> <p><span class="legendSpanClass">YOKNEAM, <location value="LC/il" idsrc="xmltag.org" >Israel</location></span>, <span class="legendSpanClass"><chron>Feb. 26, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode Ltd.</span> </b>(Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in March:</p> <div id="prni_dvprnejpg176cleft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg176cleft" title="INMODE Logo" src="https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg" alt="INMODE Logo" align="middle" data-name="url$https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1064477%2FInMode_Logo.jpg;width$400;height$223" /></div><p><b>Barclays 28^th Annual Global Healthcare Conference</b></p><p><b>Presenters: </b><person>Yair Malca</person>, Chief Financial Officer </p><p><b>Format:</b> In-person fireside chat moderated by <person>Matt Miksic</person>, Senior Equity Analyst, and one-on-one meetings</p><p><b>Location: </b><location value="LU/us.fl.miami" idsrc="xmltag.org" >Miami, FL</location></p><p><b>When:</b> Wednesday, March 11 at <chron>12:30 pm ET</chron></p><p>A live webcast of the presentation can be accessed <a target="_blank" href="https://event.webcasts.com/starthere.jsp?ei=1753373&amp;tp_key=a8a44922ad&amp;tp_special=8" target="_blank" rel="nofollow">here.</a></p><p><b>Oppenheimer http://www.streetinsider.com/Press+Releases/InMode+to+Present+at+Upcoming+Investor+Conferences/26064786.html Thu, 26 Feb 2026 08:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/PRNewswire/InMode+to+Present+at+Upcoming+Investor+Conferences/26064786.html <div class="xn-content"> <p><span class="legendSpanClass">YOKNEAM, <location value="LC/il" idsrc="xmltag.org" >Israel</location></span>, <span class="legendSpanClass"><chron>Feb. 26, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode Ltd.</span> </b>(Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in March:</p> <div id="prni_dvprnejpg176cleft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg176cleft" title="INMODE Logo" src="https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg" alt="INMODE Logo" align="middle" data-name="url$https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1064477%2FInMode_Logo.jpg;width$400;height$223" /></div><p><b>Barclays 28^th Annual Global Healthcare Conference</b></p><p><b>Presenters: </b><person>Yair Malca</person>, Chief Financial Officer </p><p><b>Format:</b> In-person fireside chat moderated by <person>Matt Miksic</person>, Senior Equity Analyst, and one-on-one meetings</p><p><b>Location: </b><location value="LU/us.fl.miami" idsrc="xmltag.org" >Miami, FL</location></p><p><b>When:</b> Wednesday, March 11 at <chron>12:30 pm ET</chron></p><p>A live webcast of the presentation can be accessed <a target="_blank" href="https://event.webcasts.com/starthere.jsp?ei=1753373&amp;tp_key=a8a44922ad&amp;tp_special=8" target="_blank" rel="nofollow">here.</a></p><p><b>Oppenheimer http://www.streetinsider.com/PRNewswire/InMode+to+Present+at+Upcoming+Investor+Conferences/26064786.html Thu, 26 Feb 2026 08:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/PRNewswire/InMode+to+Present+at+Upcoming+Investor+Conferences/26064786.html <div class="xn-content"> <p><span class="legendSpanClass">YOKNEAM, <location value="LC/il" idsrc="xmltag.org" >Israel</location></span>, <span class="legendSpanClass"><chron>Feb. 26, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode Ltd.</span> </b>(Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in March:</p> <div id="prni_dvprnejpg176cleft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg176cleft" title="INMODE Logo" src="https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg" alt="INMODE Logo" align="middle" data-name="url$https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1064477%2FInMode_Logo.jpg;width$400;height$223" /></div><p><b>Barclays 28^th Annual Global Healthcare Conference</b></p><p><b>Presenters: </b><person>Yair Malca</person>, Chief Financial Officer </p><p><b>Format:</b> In-person fireside chat moderated by <person>Matt Miksic</person>, Senior Equity Analyst, and one-on-one meetings</p><p><b>Location: </b><location value="LU/us.fl.miami" idsrc="xmltag.org" >Miami, FL</location></p><p><b>When:</b> Wednesday, March 11 at <chron>12:30 pm ET</chron></p><p>A live webcast of the presentation can be accessed <a target="_blank" href="https://event.webcasts.com/starthere.jsp?ei=1753373&amp;tp_key=a8a44922ad&amp;tp_special=8" target="_blank" rel="nofollow">here.</a></p><p><b>Oppenheimer http://www.streetinsider.com/PRNewswire/InMode+to+Present+at+Upcoming+Investor+Conferences/26064786.html Thu, 26 Feb 2026 08:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/Corporate+News/InMode+ends+review+process%2C+rejects+all+transaction+proposals/26039163.html <p>InMode Ltd. (NASDAQ: INMD) announced that its independent transaction committee has concluded its review of proposals for a potential transaction and determined that none of the final proposals received were adequate or in the best interests of the company and its shareholders.</p><p>The committee conducted a comprehensive review process with assistance from external financial and legal advisors since its formation. Following careful evaluation of the final proposals, the committee decided to discontinue the transaction process.</p><p>The medical technology company stated it will continue to review its business and growth strategy, as well as its cash allocation strategy, with a focus on enhancing http://www.streetinsider.com/Corporate+News/InMode+ends+review+process%2C+rejects+all+transaction+proposals/26039163.html Mon, 23 Feb 2026 07:02:07 -0400 INMD http://www.streetinsider.com/Mergers+and+Acquisitions/InMode+ends+review+process%2C+rejects+all+transaction+proposals/26039163.html <p>InMode Ltd. (NASDAQ: INMD) announced that its independent transaction committee has concluded its review of proposals for a potential transaction and determined that none of the final proposals received were adequate or in the best interests of the company and its shareholders.</p><p>The committee conducted a comprehensive review process with assistance from external financial and legal advisors since its formation. Following careful evaluation of the final proposals, the committee decided to discontinue the transaction process.</p><p>The medical technology company stated it will continue to review its business and growth strategy, as well as its cash allocation strategy, with a focus on enhancing http://www.streetinsider.com/Mergers+and+Acquisitions/InMode+ends+review+process%2C+rejects+all+transaction+proposals/26039163.html Mon, 23 Feb 2026 07:02:07 -0400 INMD http://www.streetinsider.com/Hot+Corp.+News/InMode+ends+review+process%2C+rejects+all+transaction+proposals/26039163.html <p>InMode Ltd. (NASDAQ: INMD) announced that its independent transaction committee has concluded its review of proposals for a potential transaction and determined that none of the final proposals received were adequate or in the best interests of the company and its shareholders.</p><p>The committee conducted a comprehensive review process with assistance from external financial and legal advisors since its formation. Following careful evaluation of the final proposals, the committee decided to discontinue the transaction process.</p><p>The medical technology company stated it will continue to review its business and growth strategy, as well as its cash allocation strategy, with a focus on enhancing http://www.streetinsider.com/Hot+Corp.+News/InMode+ends+review+process%2C+rejects+all+transaction+proposals/26039163.html Mon, 23 Feb 2026 07:02:07 -0400 INMD http://www.streetinsider.com/Hot+M+and+A/InMode+ends+review+process%2C+rejects+all+transaction+proposals/26039163.html <p>InMode Ltd. (NASDAQ: INMD) announced that its independent transaction committee has concluded its review of proposals for a potential transaction and determined that none of the final proposals received were adequate or in the best interests of the company and its shareholders.</p><p>The committee conducted a comprehensive review process with assistance from external financial and legal advisors since its formation. Following careful evaluation of the final proposals, the committee decided to discontinue the transaction process.</p><p>The medical technology company stated it will continue to review its business and growth strategy, as well as its cash allocation strategy, with a focus on enhancing http://www.streetinsider.com/Hot+M+and+A/InMode+ends+review+process%2C+rejects+all+transaction+proposals/26039163.html Mon, 23 Feb 2026 07:02:07 -0400 INMD http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Feb+23/26039123.html si-local-file:///var/storage/secattach/20260223/26039123.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Feb+23/26039123.html Mon, 23 Feb 2026 07:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Feb+23/26039123.html si-local-file:///var/storage/secattach/20260223/26039123.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++InMode+Ltd.+++++++++++++++For%3A+Feb+23/26039123.html Mon, 23 Feb 2026 07:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/Press+Releases/InMode+Announces+Conclusion+of+Independent+Transaction+Committee+Review/26039090.html <div class="xn-content"> <p><span class="legendSpanClass">YOKNEAM, <location value="LC/il" idsrc="xmltag.org" >Israel</location></span>, <span class="legendSpanClass"><chron>Feb. 23, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode Ltd.</span></b> (Nasdaq: INMD) a leading global provider of innovative medical technologies ("<b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode</span></b>" or the "<b>Company</b>"), today announced that the independent transaction committee of its Board of Directors (the "<b>Committee</b>") has completed its review of proposals received in connection with a potential transaction.</p> <div id="prni_dvprnejpg144cleft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg144cleft" title="InMode Logo" src="https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg" alt="InMode Logo" align="middle" data-name="url$https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1064477%2FInMode_Logo.jpg" /></div><p> </p><p>Since its formation, the Committee has conducted a comprehensive and independent process to evaluate proposals received over the course of its work, with the assistance http://www.streetinsider.com/Press+Releases/InMode+Announces+Conclusion+of+Independent+Transaction+Committee+Review/26039090.html Mon, 23 Feb 2026 07:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/Press+Releases/InMode+Announces+Conclusion+of+Independent+Transaction+Committee+Review/26039090.html <div class="xn-content"> <p><span class="legendSpanClass">YOKNEAM, <location value="LC/il" idsrc="xmltag.org" >Israel</location></span>, <span class="legendSpanClass"><chron>Feb. 23, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode Ltd.</span></b> (Nasdaq: INMD) a leading global provider of innovative medical technologies ("<b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode</span></b>" or the "<b>Company</b>"), today announced that the independent transaction committee of its Board of Directors (the "<b>Committee</b>") has completed its review of proposals received in connection with a potential transaction.</p> <div id="prni_dvprnejpg144cleft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg144cleft" title="InMode Logo" src="https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg" alt="InMode Logo" align="middle" data-name="url$https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1064477%2FInMode_Logo.jpg" /></div><p> </p><p>Since its formation, the Committee has conducted a comprehensive and independent process to evaluate proposals received over the course of its work, with the assistance http://www.streetinsider.com/Press+Releases/InMode+Announces+Conclusion+of+Independent+Transaction+Committee+Review/26039090.html Mon, 23 Feb 2026 07:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/PRNewswire/InMode+Announces+Conclusion+of+Independent+Transaction+Committee+Review/26039090.html <div class="xn-content"> <p><span class="legendSpanClass">YOKNEAM, <location value="LC/il" idsrc="xmltag.org" >Israel</location></span>, <span class="legendSpanClass"><chron>Feb. 23, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode Ltd.</span></b> (Nasdaq: INMD) a leading global provider of innovative medical technologies ("<b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode</span></b>" or the "<b>Company</b>"), today announced that the independent transaction committee of its Board of Directors (the "<b>Committee</b>") has completed its review of proposals received in connection with a potential transaction.</p> <div id="prni_dvprnejpg144cleft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg144cleft" title="InMode Logo" src="https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg" alt="InMode Logo" align="middle" data-name="url$https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1064477%2FInMode_Logo.jpg" /></div><p> </p><p>Since its formation, the Committee has conducted a comprehensive and independent process to evaluate proposals received over the course of its work, with the assistance http://www.streetinsider.com/PRNewswire/InMode+Announces+Conclusion+of+Independent+Transaction+Committee+Review/26039090.html Mon, 23 Feb 2026 07:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/PRNewswire/InMode+Announces+Conclusion+of+Independent+Transaction+Committee+Review/26039090.html <div class="xn-content"> <p><span class="legendSpanClass">YOKNEAM, <location value="LC/il" idsrc="xmltag.org" >Israel</location></span>, <span class="legendSpanClass"><chron>Feb. 23, 2026</chron></span> /PRNewswire/ -- <b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode Ltd.</span></b> (Nasdaq: INMD) a leading global provider of innovative medical technologies ("<b><span value="NASDAQ-NMS:INMD" idsrc="xmltag.org" >InMode</span></b>" or the "<b>Company</b>"), today announced that the independent transaction committee of its Board of Directors (the "<b>Committee</b>") has completed its review of proposals received in connection with a potential transaction.</p> <div id="prni_dvprnejpg144cleft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg144cleft" title="InMode Logo" src="https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg" alt="InMode Logo" align="middle" data-name="url$https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1064477%2FInMode_Logo.jpg" /></div><p> </p><p>Since its formation, the Committee has conducted a comprehensive and independent process to evaluate proposals received over the course of its work, with the assistance http://www.streetinsider.com/PRNewswire/InMode+Announces+Conclusion+of+Independent+Transaction+Committee+Review/26039090.html Mon, 23 Feb 2026 07:00:00 -0400 INMD O.41658003 http://www.streetinsider.com/Analyst+PT+Change/InMode+Ltd.+%28INMD%29+PT+Raised+to+%2417+at+Baird/25979347.html Baird analyst Jeff Johnson raised the price target on InMode Ltd. (NASDAQ: INMD) to $17.00 (from $16.00) while maintaining a Neutral rating. http://www.streetinsider.com/Analyst+PT+Change/InMode+Ltd.+%28INMD%29+PT+Raised+to+%2417+at+Baird/25979347.html Wed, 11 Feb 2026 07:18:03 -0400 INMD